Overview
| Dividend | 0.48 |
| Ex-Dividend Date | Mar 20, 2026 |
| Annualized Return (1Y) | -27.35% |
| Annualized Return (3Y) | -2.77% |
| Annualized Return (5Y) | -8.75% |
| Annualized Return (10Y) | -2.79% |
| Volume | 200 |
| Close | 19.29 |
| Previous Close | 19.95 |
| Worst 3Y Roll AR | -29.76% |
| Worst 5Y Roll AR | -9.09% |
| Worst 10Y Roll AR | -3.80% |
| Inception Date | Aug 23, 2012 |
Dividends
Hikma Pharmaceuticals PLC (HKMPF) Dividend Information
Hikma Pharmaceuticals PLC (HKMPF) dividend growth in the last 12 months is 75.27%
The trailing 12-month yield of Hikma Pharmaceuticals PLC is 3.03%. Its dividend history:
| Pay Date | Cash Amount |
|---|---|
| Mar 20, 2026 | $0.4813 |
| Aug 15, 2025 | $0.36 |
| Mar 21, 2025 | $0.48 |
| Mar 21, 2024 | $0.47 |
| Aug 10, 2023 | $0.25 |
| Mar 23, 2023 | $0.37 |
| Aug 18, 2022 | $0.19 |
| Mar 17, 2022 | $0.26 |
| Aug 19, 2021 | $0.13 |
| Mar 18, 2021 | $0.34 |
Hikma Pharmaceuticals PLC (HKMPF) Dividend Calculator
Dividend Growth History for Hikma Pharmaceuticals PLC (HKMPF)
|
Year
|
Payout Amount
|
Year Start Yield
|
Annual Payout Growth (YoY)
|
CAGR to 2025
|
|---|---|---|---|---|
| 2025 | $0.84 | 3.36% | 78.72% | - |
| 2024 | $0.47 | 2.06% | -24.19% | 78.72% |
| 2023 | $0.62 | 3.29% | 37.78% | 16.40% |
| 2022 | $0.45 | 1.57% | -4.26% | 23.13% |
| 2021 | $0.47 | 1.37% | 2.17% | 15.62% |
| 2020 | $0.46 | 1.78% | 15.00% | 12.80% |
| 2019 | $0.4 | 1.87% | 11.11% | 13.16% |
| 2018 | $0.36 | 2.38% | 9.09% | 12.87% |
| 2017 | $0.33 | 1.48% | 3.13% | 12.39% |
| 2016 | $0.32 | 0.97% | -8.57% | 11.32% |
| 2015 | $0.35 | 1.12% | 12.90% | 9.15% |
| 2014 | $0.31 | 1.51% | 55.00% | 9.49% |
| 2013 | $0.2 | 1.66% | 233.33% | 12.70% |
| 2012 | $0.06 | 0.52% | - | 22.51% |
Dividend Growth Chart for Hikma Pharmaceuticals PLC (HKMPF)
Performance
Hikma Pharmaceuticals PLC (HKMPF) Historical Returns And Risk Info
From 12/14/2005 to 06/03/2026, the compound annualized total return (dividend reinvested) of Hikma Pharmaceuticals PLC (HKMPF) is 5.962% . Its cumulative total return (dividend reinvested) is 117.245% .
From 12/14/2005 to 06/03/2026, the Maximum Drawdown of Hikma Pharmaceuticals PLC (HKMPF) is 89.0%.
From 12/14/2005 to 06/03/2026, the Sharpe Ratio of Hikma Pharmaceuticals PLC (HKMPF) is 0.08.
From 12/14/2005 to 06/03/2026, the Annualized Standard Deviation of Hikma Pharmaceuticals PLC (HKMPF) is 64.3%.
From 12/14/2005 to 06/03/2026, the Beta of Hikma Pharmaceuticals PLC (HKMPF) is -0.05.
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| HKMPF (Hikma Pharmaceuticals PLC) | -5.24% | -27.35% | -2.77% | -8.75% | -2.79% | NA | NA | ... | ... |
| VTSMX (VANGUARD TOTAL STOCK MARKET INDEX FUND INVESTOR SHARES) | 11.11% | 28.03% | 22.03% | 12.76% | 14.92% | 13.88% | 11.14% | ... | ... |
Return Calculator for Hikma Pharmaceuticals PLC (HKMPF)
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
Hikma Pharmaceuticals PLC (HKMPF) Historical Return Chart
Calculators
Dollar Cost Average Calculator for Hikma Pharmaceuticals PLC (HKMPF)
Retirement Spending Calculator for Hikma Pharmaceuticals PLC (HKMPF)
Rolling Returns
A rolling return for a period such as 5-year, as of a specific date, represents the investment’s performance over the preceding five years leading up to that date. In the 5-year rolling chart, the value on any given date corresponds to the annualized return for the preceding 5 years up to that very date. Thus, for instance, the chart value on 8/28/2015 reflects the annualized return from 8/28/2010 to 8/28/2015. A 5-year rolling return chart for an investment (stock, fund or portfolio) depicts the return sequence of 5-year trailing returns for the dates in the chart.
These rolling returns contrast with the most recent 3, 5, 10, and 15-year returns, as they solely depict the returns for those respective periods leading up to the most recent date, without encompassing every date in the historical record.
Rolling return charts offer a more precise insight into a portfolio’s risk and return stability (including funds or individual stocks). This is particularly true when focusing on the minimal return points within a rolling return chart as a measure of a fund or a portfolio's risk. A well-known observation, often attributed to ‘Murphy’s law’, is that it tends to perform poorly when investors decide to follow an investment due to its recent strong returns. Sound familiar? Information regarding minimum rolling returns could help mitigate this predicament. Investors can opt for an investment showcasing high minimum rolling returns within their preferred holding durations. In fact, merely possessing knowledge of such minimum rolling period returns can anchor investors’ expectations.
For instance, let’s consider an investor who follows a model portfolio (or even simply purchases and holds a fund like VFINX or SPY) for 10 years. Armed with knowledge of this portfolio’s minimum 10-year rolling return since its inception date or the fund’s inception (in the case of VFINX, recognizing that the minimum 10-year rolling return since 1987 could be as low as -2.24%), the investor should reasonably anticipate the potential for the portfolio to incur losses over the forthcoming 10 years.
Minimum rolling return for a period such as 10-year offers a different and often better historical risk and return metric than other popular risk and return metrics such as Sharpe ratio, standard deviation (volatility) or maximum drawdown.
See Portfolio Calculator and Rolling Returns for more detailed description.
Drawdowns
Hikma Pharmaceuticals PLC (HKMPF) Maximum Drawdown
Retirement Plan (401(k)) Info for Hikma Pharmaceuticals PLC (HKMPF)
Related Articles for Hikma Pharmaceuticals PLC(HKMPF)
